Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00181142
What this trial is testing

The Use of Daclizumab and Anti-Thymocyte Globulin in Lung Transplantation

Who this might be right for
Patients Active and Listed for Lung Transplantation
Johns Hopkins University 60
Testing effectiveness (Phase 2)Study completedNCT00944749
What this trial is testing

Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment

Who this might be right for
Anemia, AplasticAnemia, Hypoplastic
National Heart, Lung, and Blood Institute (NHLBI) 23
Post-approval studies (Phase 4)Study completedNCT00488436
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome
PETHEMA Foundation 25
Testing effectiveness (Phase 2)Study completedNCT00005937
What this trial is testing

Antithymocyte Globulin and Cyclosporine to Treat Myelodysplasia

Who this might be right for
Myelodysplastic Syndrome
Neal Young, M.D. 42
Post-approval studies (Phase 4)Study completedNCT01336296
What this trial is testing

Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients

Who this might be right for
Kidney Transplant Recipients
University of Cincinnati 61
Testing effectiveness (Phase 2)Looking for participantsNCT07061574
What this trial is testing

Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

Who this might be right for
Type 1 DiabetesNew Onset
City of Hope Medical Center 120
Testing effectiveness (Phase 2)Study completedNCT00072969
What this trial is testing

Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndromes
National Heart, Lung, and Blood Institute (NHLBI) 132
Testing effectiveness (Phase 2)Ended earlyNCT01994824
What this trial is testing

Preemptive Therapy of GVHD

Who this might be right for
Graft-vs-host Disease
University of Calgary 70
Testing effectiveness (Phase 2)Study completedNCT00813124
What this trial is testing

Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

Who this might be right for
Stem Cell TransplantationLeukemia
M.D. Anderson Cancer Center 24
Testing effectiveness (Phase 2)Study completedNCT00054340
What this trial is testing

Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+2 more
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)Looking for participantsNCT06895538
What this trial is testing

Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy

Who this might be right for
LeukemiaMDSLymphoma
Peking University First Hospital 24
Testing effectiveness (Phase 2)Study completedNCT00001626
What this trial is testing

Comparing Therapies for the Treatment of Severe Aplastic Anemia

Who this might be right for
Severe Aplastic Anemia (SAA)
National Heart, Lung, and Blood Institute (NHLBI) 33
Testing effectiveness (Phase 2)Study completedNCT00305708
What this trial is testing

Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission

Who this might be right for
Congenital Amegakaryocytic ThrombocytopeniaDiamond-blackfan AnemiaFanconi Anemia+3 more
University of California, San Francisco 40
Not applicableStudy completedNCT05029206
What this trial is testing

Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Uppsala University 174
Not applicableStudy completedNCT01272817
What this trial is testing

Nonmyeloablative Allogeneic Transplant

Who this might be right for
Aplastic AnemiaParoxysmal Nocturnal HemoglobinuriaAcute Myelogenous Leukemia+15 more
Scripps Health 36
Not applicableStudy completedNCT00427336
What this trial is testing

Purine Analog-Based Conditioning in Patients With Severe Aplastic Anemia

Who this might be right for
Aplastic Anemia
M.D. Anderson Cancer Center 9
Testing effectiveness (Phase 2)Study completedNCT00589563
What this trial is testing

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseInfection+8 more
City of Hope Medical Center 32
Testing effectiveness (Phase 2)Study completedNCT01056614
What this trial is testing

Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionAdult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities+17 more
Fred Hutchinson Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT01375023
What this trial is testing

Allogenic Haematopoietic Cell Transplantation for Patients With Refractory "Triple Negative" Breast Cancer

Who this might be right for
Breast Cancer
European Institute of Oncology 3
Testing effectiveness (Phase 2)Study completedNCT01490723
What this trial is testing

Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

Who this might be right for
LeukemiaLymphoma
M.D. Anderson Cancer Center 20
Next Page